Coya Therapeutics (COYA) Prepaid Assets (2021 - 2026)
Coya Therapeutics (COYA) reported Prepaid Assets of $1.8 million for Q1 2026, up 1118.25% on a YoY basis from $143949.0 in Q1 2025, and up 137.57% sequentially from $738157.0 in Q4 2025.
Coya Therapeutics (COYA) Prepaid Assets (2021 - 2026) Analysis & Trends
Coya Therapeutics (COYA) has 6 years of Prepaid Assets data on file, last reported at $1.8 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets rose 1118.25% year-over-year to $1.8 million; the trailing twelve-month figure through Mar 2026 stood at $1.8 million (up 1118.25% YoY), and the FY2025 full-year result was $738157.0, down 81.57% from the prior year.
- Prepaid Assets improved to $1.8 million in Q1 2026, from $738157.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $4.4 million in Q3 2024 to a low of $24075.0 in Q4 2022.
- A 5-year average of $1.5 million and a median of $974161.5 in 2023 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets surged 4556.4% in 2024 and sank 95.67% in 2025, its largest moves.
- Tracing COYA's Prepaid Assets over 5 years: stood at $24075.0 in 2022, then soared by 257.28% to $86016.0 in 2023, then surged by 4556.4% to $4.0 million in 2024, then tumbled by 81.57% to $738157.0 in 2025, then soared by 137.57% to $1.8 million in 2026.
- Business Quant data shows COYA's Prepaid Assets at $1.8 million in Q1 2026, $738157.0 in Q4 2025, and $3.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,681.27 Bn | 66,680.98 Bn | - |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 472.75 Bn | 467.96 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.14 Bn | 114.89 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.94 Bn | 50.76 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.52 Bn | 34.51 Bn | 959.66 Mn |
| 10 | Coya Therapeutics | 97.71 Mn | 46.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.75 Mn |
| Dec 31, 2025 | 738,157.00 |
| Sep 30, 2025 | 3.89 Mn |
| Jun 30, 2025 | 119,822.00 |
| Mar 31, 2025 | 143,949.00 |
| Dec 31, 2024 | 4.01 Mn |
| Sep 30, 2024 | 4.45 Mn |
| Jun 30, 2024 | 2.77 Mn |
| Mar 31, 2024 | 148,788.00 |
| Dec 31, 2023 | 86,016.00 |
| Sep 30, 2023 | 936,354.00 |
| Jun 30, 2023 | 1.29 Mn |
| Mar 31, 2023 | 1.01 Mn |
| Dec 31, 2022 | 24,075.00 |
| Dec 31, 2021 | 34,047.00 |